SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Azza Hamdy El Sissy, Maha H. El Sissy, Shereef Elmoamly, Factor V Leiden 1691G/A and prothrombin gene 20210G/A polymorphisms as prothrombotic markers in adult Egyptian acute leukemia patients, Medical Oncology, 2014, 31, 11

    CrossRef

  2. 2
    A Richters, M van Vliet, P G M Peer, P E Verweij, B A P Laros-van Gorkom, N M A Blijlevens, J P Donnelly, W J F M van der Velden, Incidence of and risk factors for persistent gram-positive bacteraemia and catheter-related thrombosis in haematopoietic stem cell transplantation, Bone Marrow Transplantation, 2014, 49, 2, 264

    CrossRef

  3. 3
    Mari Tinholt, Marte Viken, Anders Dahm, Hans Vollan, Kristine Sahlberg, Øystein Garred, Anne-Lise Børresen-Dale, Anne Jacobsen, Vessela Kristensen, Ida Bukholm, Rolf Kåresen, Ellen Schlichting, Grethe Skretting, Benedicte Lie, Per Sandset, Nina Iversen, Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study, BMC Cancer, 2014, 14, 1, 845

    CrossRef

  4. 4
    D. M. SIEGAL, D. GARCIA, Anticoagulants in cancer, Journal of Thrombosis and Haemostasis, 2012, 10, 11
  5. 5
    Metin OZKAN, Serdar SIVGIN, Ismail KOCYIGIT, Funda EMIROGULLARI, Mustafa DIKILITAS, Leylagul KAYNAR, Yusuf OZKUL, Ozlem ER, Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?, Asia-Pacific Journal of Clinical Oncology, 2012, 8, 3
  6. 6
    Dilara Fatma Akın, Kadir Sipahi, Tuğba Kayaalp, Yonca Eğin, Serpil Taşdelen, Emin Kürekçi, Üstün Ezer, Nejat Akar, Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients, Leukemia Research and Treatment, 2012, 2012, 1

    CrossRef

  7. 7
    M. Mandala, S. Barni, M. Prins, R. Labianca, C. Tondini, L. Russo, A. Milesi, M. Cremonesi, M. Zaccanelli, C. Regonesi, C. Moro, A. Falanga, Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial, Annals of Oncology, 2010, 21, 4, 871

    CrossRef

  8. 8
    Aydan Eroglu, Ragip Çam, Yonca Eğin, Nejat Akar, Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer, Breast Cancer Research and Treatment, 2009, 116, 3, 619

    CrossRef

  9. 9
    Aydan Eroglu, Yonca Egin, Ragip Çam, Nejat Akar, The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis, Annals of Hematology, 2009, 88, 1, 73

    CrossRef

  10. 10
    Wolfgang Korte, Cancer and thrombosis: an increasingly important association, Supportive Care in Cancer, 2008, 16, 3, 223

    CrossRef

  11. 11
    Lois W. Brüggemann, Henri H. Versteeg, Tatjana M. Niers, Pieter H. Reitsma, C. Arnold Spek, Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders, Journal of Cellular and Molecular Medicine, 2008, 12, 6b
  12. 12
    I. Elalamy, E. Verdy, G. Gerotziafas, M. Hatmi, Physiopathogénie de la maladie thromboembolique veineuse au cours du cancer, Pathologie Biologie, 2008, 56, 4, 184

    CrossRef

  13. 13
    R. Descourt, M. Righini, M. Carrier, G. Le Gal, Place du cancer parmi les facteurs de risque de la maladie thromboembolique veineuse, Pathologie Biologie, 2008, 56, 4, 178

    CrossRef

  14. 14
    H. R. BULLER, F. F. VAN DOORMAAL, G. L. VAN SLUIS, P. W. KAMPHUISEN, Cancer and thrombosis: from molecular mechanisms to clinical presentations, Journal of Thrombosis and Haemostasis, 2007, 5,
  15. 15
    Jeffrey I. Zwicker, Barbara C. Furie, Bruce Furie, Cancer-associated thrombosis, Critical Reviews in Oncology/Hematology, 2007, 62, 2, 126

    CrossRef

  16. 16
    C.P.W. Klerk, S.M. Smorenburg, C.A. Spek, C.J.F. Van Noorden, Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation, Journal of Cellular and Molecular Medicine, 2007, 11, 3
  17. 17
    Aydan Eroglu, Arzu Ulu, Ragip Çam, Cengiz Kurtman, Nejat Akar, Prevalence of Factor V 1691 G–A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients, Journal of Thrombosis and Thrombolysis, 2007, 23, 1, 31

    CrossRef

  18. 18
    Emmanuel Mitry, Raffic Taleb-Fayad, Antoine Deschamps, Nicolas Mansencal, Céline Lepère, Gilles Declety, Astrid Lièvre, Jean-Nicolas Vaillant, Gilles Lesur, Élisabeth Cramer, Olivier Dubourg, Philippe Rougier, Risk of venous thrombosis in patients with pancreatic adenocarcinoma, Gastroentérologie Clinique et Biologique, 2007, 31, 12, 1139

    CrossRef

  19. 19
    Hervé Decousus, Nathalie Moulin, Sara Quenet, Vincent Bost, Karine Rivron-Guillot, Silvy Laporte, Patrick Mismetti, Thrombophilia and risk of venous thrombosis in patients with cancer, Thrombosis Research, 2007, 120, S51

    CrossRef

  20. 20
    J Blom, C Doggen, F Rosendaal, Cancer-Associated Thrombosis, 2007,

    CrossRef

  21. 21
    E. Vairaktaris, C. Yapijakis, P. Kessler, A. Vylliotis, J. Ries, J. Wiltfang, S. Vassiliou, S. Derka, F. W. Neukam, Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer, Journal of Cancer Research and Clinical Oncology, 2006, 132, 4, 219

    CrossRef

  22. 22
    Margaret Kennedy, Astrid C. M. Andreescu, Marc S. Greenblatt, Hongyu Jiang, Christian A. Thomas, Laurie Chassereau, Cheung Wong, Peter Durda, Mary Cushman, Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients, British Journal of Haematology, 2005, 128, 3
  23. 23
    Shuwei Gao, Carmen Escalante, Venous thromboembolism and malignancy, Expert Review of Anticancer Therapy, 2004, 4, 2, 303

    CrossRef